CRP and ovarian carcinoma: SNK analysis showed significant CRP increases in levels in cancer patients and controls (UF vs early stage, P=0.003; UF vs late stage, P=0.003; BOT vs early stage, P=0.014; BOT vs late stage, P=0.018), but there were no differences between early stage and late stage of ovarian cancers.